4//SEC Filing
Halfon Jean Michel 4
Accession 0001209191-20-046587
CIK 0000818686other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 4:10 PM ET
Size
7.4 KB
Accession
0001209191-20-046587
Insider Transaction Report
Form 4
Halfon Jean Michel
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2020-08-11+7,956→ 30,519 total - Exercise/Conversion
Restricted Share Units
2020-08-11−7,956→ 0 total→ Ordinary Shares (7,956 underlying)
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on August 11, 2017 and vested on August 11, 2020.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001721516
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 4:10 PM ET
- Size
- 7.4 KB